‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses (2017)
Journal Article
Johnson, C. F., Williams, B., MacGillivray, S. A., Dougall, N. J., & Maxwell, M. (2017). ‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses. BMC Family Practice, 18(1), https://doi.org/10.1186/s12875-017-0643-z

Background: Antidepressant prescribing continues to increase, with 5-16% of adults receiving antidepressants annually. Total prescribing growth is due in part to increased long-term use, greater selective serotonin re-uptake inhibitor (SSRI) use and... Read More about ‘Doing the right thing’: factors influencing GP prescribing of antidepressants and prescribed doses.

A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET (1996)
Journal Article
Prentice, N., Van Beck, M., Dougall, N. J., Moffoot, A. P. R., O'Carroll, R. E., Goodwin, G. M., & Ebmeier, K. P. (1996). A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET. Journal of Psychopharmacology, 10(3), 175-181. https://doi.org/10.1177/026988119601000301

Background: the effect of single-dose and long-term cholinergic enhancement with tacrine on regional cerebral perfusion was examined in patients with Alzheimer's disease using single-photon emission tomography (SPET). Method: 23 patients with probabl... Read More about A double-blind, placebo-controlled study of tacrine in patients with Alzheimer's disease using SPET.